Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2025.
BLACKROSE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Black Rose Industries reported Q1 FY2026 standalone revenue from operations of ₹5,984.95 lakhs, down about 19% from ₹7,417.56 lakhs in Q1 FY2025. Standalone profit after tax fell to ₹424.17 lakhs from ₹468.17 lakhs, with basic EPS at ₹0.83 vs ₹0.82. On a consolidated basis, revenue dropped much more sharply to ₹5,984.95 lakhs from ₹9,826.89 lakhs (roughly 39% lower), as the Japan subsidiary's operations had been discontinued from 30 January 2025; consolidated PAT was ₹418.90 lakhs versus ₹471.99 lakhs. The Board also approved closure/sale/transfer of its 100% stake in B.R. Chemicals Co. Ltd. (Japan), which contributed 13.57% of consolidated income and 3.67% of net worth last year. Additionally, CFO Ratan Agrawal was made Chief Risk Officer, new Senior Management Personnel were designated, and M/s. Shiv Hari Jalan & Co. was appointed as Secretarial Auditor for 5 years (FY2025-26 to FY2029-30).
Investors should note the sharp topline decline, largely explained by the discontinued Japan operations, with PAT only modestly lower. The planned divestment of the Japan subsidiary signals a strategic simplification and could affect consolidated reporting going forward.